Current filters:

Cardizem LA

1 to 9 of 252 results

Biovail pleads guilty to DOJ charges, agrees to pay $24.6M


Biovail has reached an agreement with the US Department of Justice over criminal allegations related…

Cardizem LADiltiazem

KV's fiscal 3rd-qtr net revenue jumps 39%


The USA's KV Pharmaceuticals says net revenues for the third quarter of fiscal 2008 increased to $163.7…

AstraZenecaCardizem LADiltiazemDiltiazem HclMetoprolol SuccinateTiazacToprol XL

Tanabe's turnover up 1.3% by 3rd-qtr 2005


Japanese drugmaker Tanabe says its turnover increased 1.3% to 138.2 billion yen ($1.17 billion) for the…

Cardizem LACeftazidimeCeptazDiltiazemFortazGlaxoSmithKlineGSKinfliximabRemicade

Tanabe sees 1% sales dip in fiscal half-year


Japanese drugmaker Tanabe has reported sales of 83.5 billion yen ($699.2 million), a 1.1% decline on…

Cardizem LADiltiazem

Kos enters cardiovascular R&D alliance with Biovail


US firm Kos Pharmaceuticals has entered into a strategic commercialization and R&D alliance with Canada's…

Cardizem LADiltiazemDiltiazem HclEnalaprilEprosartan MesylateEprosartan Mesylate Hydrochlorothiazide TableSolvayTevetenTeveten HCTTiazacVasotec

Non-pharma business hits Tanabe's 3rd-qtr


As a result of poor performances from non-pharmaceutical operations, Japan's Tanabe reported weak consolidated…

Cardizem LADiltiazeminfliximabRemicade

Bama-Geve sees 2005 sales up 13% in Spain


Italian drugs company Bama-Geve expects sales to rise 13.0% in Spain this year to 14.5 million euros…

Cardizem LADiltiazemIsmoIsosorbide Mononitrate

1 to 9 of 252 results

Back to top